News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

|Podcasts|April 21, 2011

Global Regulatory Capacity

Global Regulatory Capacity

Paul Pomerantz, Worldwide Executive Director of the Drug Information Association, discusses the issues taxing regulatory agencies worldwide as well as clinical trial complexity, lack of global harmonization, regulatory workload and more.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

February 7th 2025

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

January 6th 2023

The Evolving Relationship Between Sponsors and the Contract Research Organizations

December 8th 2022

The MDR: Navigating Europe’s New Standard for Medical Device Safety

October 25th 2022

Trending on Applied Clinical Trials Online

ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward

Reducing Site Burden Through Better Technology Integration in Clinical Trials

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

© 2025 MJH Life Sciences^®

All rights reserved.